Policyholder Services

FDA Alert – Artificial Tears

On Feb. 3, the US Food and Drug Administration (FDA) issued a warning statement to consumers and health care practitioners to not purchase and to immediately stop using EzriCare Artificial Tears and Delsam Pharma’s Artificial Tears, due to potential bacterial contamination. Both products have been voluntarily recalled.

The Centers for Disease Control (CDC) has developed related resources for health care providers:

• • • Sample Customizable Patient Notification Letter
    • Provider Talking Points about Artificial Tears

The CDC continues to investigate the multistate outbreak of an extensively drug-resistant strain of Pseudomonas aeruginosa associated with artificial tears.